Landmark multi-year patent battle in China ends with foreign biotech innovator coming out on top

In what it hailed as a “landmark” biotech patent validity case, Danish company Novozymes has won out in  a six year patent fight with major Chinese competitors following a judgment from the Supreme People’s Court. The result is important because…